Aroa Biosurgery Secures FDA Clearance for Symphony
Filed with ASX · · 2 pages · English
In the deck
Earlier from Aroa Biosurgery
Later from Aroa Biosurgery
- Aroa Half Year Results
- S&P DJI Announces March 2021 Quarterly Rebalance
- Aroa secures FDA clearance for new product
- Preliminary Final Report
- FY21 Full Year Results Presentation
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery